| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/27/1993 | WO1993010215A1 Purified proteoglycan betaglycan, compositions, and methods |
| 05/27/1993 | WO1993010155A1 6(r)-l-erythro-5,6,7,8-tetrahydrobiopterin receptor |
| 05/27/1993 | WO1993010154A1 High molecular weight collagen-like protein polymers |
| 05/27/1993 | WO1993010153A1 Bactericidal product, pharmaceutical composition containing same and food additive |
| 05/27/1993 | WO1993010151A1 Receptor for oncostatin m and leukemia inhibitory factor |
| 05/27/1993 | WO1993010148A1 Muramyl compounds for treatment of septic shock |
| 05/27/1993 | WO1993010146A1 Amylin agonist peptides and uses therefor |
| 05/27/1993 | WO1993010145A1 Compositions for delayed treatment of ischemia-related neuronal damage |
| 05/27/1993 | WO1993010144A1 New endothelin antagonists and their preparation |
| 05/27/1993 | WO1993010143A1 Antihemophilic factor stabilization |
| 05/27/1993 | WO1993009869A1 Adsorbent for blood coagulation factor viii |
| 05/27/1993 | WO1993009816A1 Method for diagnosing and treating cancer |
| 05/27/1993 | WO1993009815A1 Specific tolerance in transplantation |
| 05/27/1993 | WO1993009812A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 05/27/1993 | WO1993009810A1 Mhc subunit conjugates useful in ameliorating deleterious immune responses |
| 05/27/1993 | WO1993009808A1 METHODS FOR DETECTING AND ISOLATING uPA-R AND INHIBITING THE BINDING OF uPA TO uPA-R |
| 05/27/1993 | WO1993009807A1 Methods of inhibiting thrombosis via elevation of circulating endogenous activated protein c levels |
| 05/27/1993 | WO1993009806A1 Nitrosylation of protein sh groups and amino acid residues as a therapeutic modality |
| 05/27/1993 | WO1993009805A1 Polar lipid composition of plant origin |
| 05/27/1993 | WO1993009804A1 Serine protease derived-polypeptides and anti-peptide antibodies, systems and therapeutic methods for inhibiting coagulation |
| 05/27/1993 | WO1993009803A1 Factor x-derived polypeptides and anti-peptide antibodies, systems and therapeutic methods for inhibiting inflammation |
| 05/27/1993 | WO1993009802A2 Tgf-beta to improve neural outcome |
| 05/27/1993 | WO1993009801A1 Method of treating hyperlipidemia |
| 05/27/1993 | WO1993009800A1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring |
| 05/27/1993 | WO1993009799A1 Suppression of megakaryocytopoiesis by macrophage inflammatory proteins |
| 05/27/1993 | WO1993009798A1 Therapeutic and diagnostic methods based on tissue specific nt-3 expression and receptor binding |
| 05/27/1993 | WO1993009797A1 Treatment of macrophages |
| 05/27/1993 | WO1993009796A1 Use of interleukin-8 |
| 05/27/1993 | WO1993009795A1 Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them |
| 05/27/1993 | WO1993009794A1 Suppression of megakaryocytopoiesis by neutrophil activating peptide-2 |
| 05/27/1993 | WO1993009790A1 Methods of inhibiting restenosis |
| 05/27/1993 | WO1993009789A1 Treatment of melanoma with antisense oligonucleotides to c-myb proto-oncogene |
| 05/27/1993 | WO1993009765A1 Polymer-based osmotic drug delivery system |
| 05/27/1993 | WO1993009764A1 Combined virustatic antimediator (covam) treatment of common colds |
| 05/27/1993 | WO1993007866A3 Compositions and methods for therapy and prevention of cancer, aids, and anemia |
| 05/27/1993 | WO1993006812A3 Use of an emulsion to prepare an intravenously administered medicament for treating skin diseases |
| 05/27/1993 | WO1993006218A3 Chimeras of parainfluenza virus type 3 proteins f and hn as vaccines |
| 05/27/1993 | WO1993006130A1 Neurotensin method for inhibiting vascular leakage |
| 05/27/1993 | WO1993003058A3 Non-desensitizing analogs of gnrh and other biologically active ligands |
| 05/27/1993 | WO1993001820A3 Inhibition of non-cd4 mediated hiv infection |
| 05/27/1993 | DE4209110A1 Neue thrombininhibitorische proteine aus landblutegeln Country leeches novel thrombin proteins from |
| 05/27/1993 | CA2378820A1 Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes |
| 05/27/1993 | CA2124857A1 Methods of inhibiting restenosis |
| 05/27/1993 | CA2123874A1 Methods for detecting and isolating upa-r and inhibiting the binding of upa to upa-r |
| 05/27/1993 | CA2123611A1 Treatment of melanoma with antisense oligonucleotides to c-myb proto-oncogene |
| 05/27/1993 | CA2123588A1 Method for diagnosing and treating cancer |
| 05/27/1993 | CA2123587A1 Bactericide product; pharmaceutical composition and food additive containing the same |
| 05/27/1993 | CA2123585A1 Polar lipidic composition from plants |
| 05/27/1993 | CA2123420A1 Protease vaccine against heartworm |
| 05/27/1993 | CA2123418A1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring |
| 05/27/1993 | CA2123395A1 New endothelin antagonists and their preparation |
| 05/27/1993 | CA2123323A1 Dna encoding a glycine transporter and uses thereof |
| 05/27/1993 | CA2123316A1 High molecular weight collagen-like protein polymers |
| 05/27/1993 | CA2123234A1 Synthesis and purification of truncated and mutein forms of human ciliary neuronotrophic factor |
| 05/27/1993 | CA2123228A1 Mhc subunit conjugates useful in ameliorating deleterious immune responses |
| 05/27/1993 | CA2123210A1 Protein allergens of the species cynodon dactylon |
| 05/27/1993 | CA2122719A1 Combined virustatic antimediator (covam) treatment of common colds |
| 05/27/1993 | CA2118805A1 Neurotensin method for inhibiting vascular leakage |
| 05/27/1993 | CA2117285A1 Use of interleukin-8 |
| 05/27/1993 | CA2117282A1 Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprosing them |
| 05/27/1993 | CA2083622A1 Certain macrocyclic lactam derivatives |
| 05/27/1993 | CA2083360A1 Tri-arginine insulins |
| 05/26/1993 | EP0543521A2 High dosage topical forms of collagenase |
| 05/26/1993 | EP0543476A1 Use of interleukin-8 |
| 05/26/1993 | EP0543425A1 Endothelin DNA and use thereof |
| 05/26/1993 | EP0543310A2 Dipeptide derivative and prophylactic and therapeutic agent for bone diseases containing the same |
| 05/26/1993 | EP0543240A1 Polypeptide, DNA fragment encoding the same, drug composition containing the same and process for producing the same |
| 05/26/1993 | EP0543178A2 Process of preparation of a virus-free thrombin concentrate |
| 05/26/1993 | EP0543076A2 Wheat alpha-amylase inhibitor for the treatment of diabetes |
| 05/26/1993 | EP0542971A1 CLONING AND RECOMBINANT PRODUCTION OF RECEPTOR(S) OF THE ACTIVIN/TGF-$g(b) SUPERFAMILY |
| 05/26/1993 | EP0542970A1 Nucleotide and peptide sequences of an isolate of the hepatitis c virus, diagnostic and therapeutic applications thereof |
| 05/26/1993 | EP0542937A1 Growth hormone releasing factor analogs |
| 05/26/1993 | EP0542934A1 Method of treating benign and malignant proliferative skin disease |
| 05/26/1993 | EP0542920A1 Cannabinoid receptor |
| 05/26/1993 | EP0542914A1 Improved diagnostic and therapeutic compositions |
| 05/26/1993 | EP0542899A1 Peptides of the chromostatin family |
| 05/26/1993 | EP0542892A1 Chimeric neurotrophic factors |
| 05/26/1993 | EP0542880A1 Tissue bonding and sealing composition and method of using the same |
| 05/26/1993 | EP0542860A1 Immunosuppressive compositions |
| 05/26/1993 | EP0542843A1 Cloning and expression of toxoplasma antigens and use of recombinant antigens |
| 05/26/1993 | EP0542770A1 Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
| 05/26/1993 | EP0528881A4 Methods for phenotype creation from multiple gene populations |
| 05/26/1993 | EP0527802A4 Ligand for the neu gene product |
| 05/26/1993 | EP0513150A4 New method for treating immunodeficiency or neutropenia |
| 05/26/1993 | EP0489836A4 Light activated acyl-enzymes |
| 05/26/1993 | EP0397679B1 New anti-inflammatory agents |
| 05/26/1993 | EP0373218B1 Kidney growth accelerator and process for its preparation |
| 05/26/1993 | EP0331756B1 Agents for prophylaxis and treatment of thrombopenia |
| 05/26/1993 | EP0167575B1 Cardiodilatine, a new peptide hormone and production process thereof |
| 05/26/1993 | CN1072415A Cyclic vasoactive peptides |
| 05/26/1993 | CN1072344A Venin cream |
| 05/26/1993 | CN1020924C Production of pluripotent granule cell colony stimulating factor |
| 05/26/1993 | CN1020857C Peptides corresponding to antigenic and immunogenic determinants of major nentralizing proteins of rotaviruses |
| 05/26/1993 | CN1020851C Controlled release delivery system for macromolecules |
| 05/25/1993 | US5214181 Immunodeficiency and autoimmune disease treatment |
| 05/25/1993 | US5214133 SCL: a hematopoietic growth and differentiation factor |
| 05/25/1993 | US5214132 Polypeptide derivatives of human granulocyte colony stimulating factor |
| 05/25/1993 | US5214130 Synthesis of novel immunosuppressive cyclosporin analogs with modified amino acids at position-8 |
| 05/25/1993 | US5214129 Peptidylaminodiols |
| 05/25/1993 | US5214062 Method and composition for treating immune disorders, inflammation and chronic infections |